Kim Kardashian Warned by FDA For Promoting Drug on Social Media


Kim Kardashian and a drug manufacturer got in trouble after Kardashian promoted a drug on her social media accounts. The Federal Drug Administration issued a warning letter to the makers. It says the...

Sanofi Buys Rare Cancer Drug for up to $300 Million from AstraZeneca


Sanofi is making some deals that the chief executive of the company Pascal Soriot is arguing as a potential threat to the company’s financial state but Sanofi believes that buying the drugs that are...

AstraZeneca spurns Pfizer’s Massive Offer


AstraZeneca deftly turned away an offer that many others probably wouldn’t have been able to resist. The $117 billion being given for a merger of the two companies by Pfizer was rejected. The...

Weight Loss: Glaxo Recalls Alli Weight Loss Drugs


Glaxo has doubts that its Alli weight loss products are being tempered. Actually GlaxoSmithKline (GSK) Consumer Healthcare has received complaints about its Alli weight loss products from seven...

Alli Weight Loss Products Recalled


GlaxoSmithKline (GSK) Consumer Healthcare has received complaints about its Alli weight loss products from seven states. That is why, GSK has announced yesterday that it is "voluntarily recalling all...

Investing in the Future of Medicine: In Vitro Diagnostics Market


In spite of all the advances we’ve made in medicine, people still get sick. But thankfully, we’re continuously getting better with our ability to diagnose. One clear way medicine is improving is the...

Rx For Software: Can Medidata Solutions Save Drug Companies Billions Of Dollars?


Tarek Sherif, a small-time fund manager, plopped his cathode-ray-tube monitor and desktop computer on an office chair and wheeled it a mile down Park Avenue from his fund’s offices into a small room...

Johnson & Johnson Shares Clinical Trial Data


In a major victory for advocates of open access to data from clinical trials, Johnson & Johnson today announced that it will make all of its clinical trial data available to outside researchers....